Cencora, Inc. - SIC # 7690 -

Ticker Exchange SIC # Website Latest Ticker
COR New York 7690 www.cencora.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cencora, Inc.

Tris Pharma Introduces a New 60 mL Bottle Size for DYANAVEL® XR (amphetamine) Extended-Release Oral Suspension CII - Jun 8th, 2026 11:12 am
Is Cencora Stock Underperforming the Nasdaq? - Jun 8th, 2026 7:55 am
Cencora (COR) Up 5.7% Since Last Earnings Report: Can It Continue? - Jun 5th, 2026 9:30 am
Wall Street Analysts Predict a 33.55% Upside in Cencora (COR): Here's What You Should Know - Jun 5th, 2026 7:55 am
Is McKesson Stock Underperforming the Dow? - Jun 3rd, 2026 5:05 am
Cencora to Support U.S. Distribution of Kite’s CAR T-Cell Therapies - Jun 2nd, 2026 6:00 am
Is Cencora’s New CFO, $2 Billion Buyback, and Lawsuit Trio Altering The Investment Case For Cencora (COR)? - Jun 1st, 2026 5:11 pm
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - Jun 1st, 2026 12:39 pm
LUCENT Appoints Simon Doyle as CEO with Matthew Goodman Taking Chief Medical Officer Position - Jun 1st, 2026 1:00 am
Cencora nabs ex-CVS exec as new CFO - May 27th, 2026 5:14 am
Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer - May 27th, 2026 4:55 am
Cencora Announces Updated Fiscal Year 2026 Financial Outlook - May 21st, 2026 2:30 pm
3 Market-Beating Stocks to Research Further - May 18th, 2026 11:32 pm
Cencora (COR) Emerges as a Healthcare Leader with Robust Fundamentals and Strategic Re-Rating - May 18th, 2026 6:36 am
Cencora Legal Probes Test Investor Confidence After Weaker Q2 Revenue Outlook - May 17th, 2026 3:13 pm
The Top 5 Analyst Questions From Cencora’s Q1 Earnings Call - May 16th, 2026 3:56 pm
Wells Fargo Maintains Overweight Rating on Cencora (COR) - May 15th, 2026 7:25 am
CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell? - May 14th, 2026 11:06 am
Can CAH Sustain Growth on Booming Pharmaceutical & Specialty Segment? - May 13th, 2026 8:40 am
Cencora Q2 Earnings Call Highlights - May 9th, 2026 3:04 pm